Scientific Opinion on the safety of caffeine

EFSA Journal

Volumn 13, Issue 5, 2015, Pages

[No Author Info available]

Author keywords

alcohol; caffeine; D glucurono lactone; p synephrine; physical activity; taurine; energy drinks

Indexed keywords

EID: 85065470947     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2015.4102     Document Type: Article

References (312)

1. Abernethy DR and Todd EL, 1985. Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives. European Journal of Clinical Pharmacology, 28, 425–428.
2. Abernethy DR, Todd EL and Schwartz JB, 1985. Caffeine disposition in obesity. British Journal of Clinical Pharmacology, 20, 61–66.
3. Agudelo GM, Velasquez CM, Cardona OL, Duque M, Posada M and Pineda V, 2008. Changes in blood pressure in a group of normotensevolunteers after consumption or different doses of filtered coffee. Revista Colombiana de Cardiología, 15, 289–296.
4. Ahmed HN, Levitan EB, Wolk A and Mittleman MA, 2009. Coffee consumption and risk of heart failure in men: an analysis from the Cohort of Swedish Men. American Heart Journal, 158, 667–672.
5. Aldridge A, Aranda JV and Neims AH, 1979. Caffeine metabolism in the newborn. Clinical Pharmacology and Therapeutics, 25, 447–453.
6. Aldridge A, Bailey J and Neims AH, 1981. The disposition of caffeine during and after pregnancy. Seminars in Perinatology, 5, 310–314.
7. Alford C, Hamilton-Morris J and Verster JC, 2012. The effects of energy drink in combination with alcohol on performance and subjective awareness. Psychopharmacology, 222, 519–532.
8. Alsene K, Deckert J, Sand P and De Wit H, 2003. Association between A(2a) receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology, 28, 1694–1702.
9. Ammon HP, Bieck PR, Mandalaz D and Verspohl EJ, 1983. Adaptation of blood pressure to continuous heavy coffee drinking in young volunteers. A double-blind crossover study. British Journal of Clinical Pharmacology, 15, 701–706.
10. Ammon HP, 1991. Biochemical mechanism of caffeine tolerance. Archiv der Pharmazie (Weinheim), 324, 261–267.
11. Andersen LF, Jacobs DR Jr, Carlsen MH and Blomhoff R, 2006. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. American Journal of Clinical Nutrition, 83, 1039–1046.
12. Anderson TJ, 2006. Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk. Canadian Journal of Cardiology, 22(Suppl. B), 72–80.
13. ANSES (Agence nationale de sécurité sanitaire de l'alimentation), 2013. Opinion of the French Agency for Food, Environmental and Occupational Health & Safety on the assessment of risks concerning the consumption of so-called “energy drinks”. Opinion Request no 2012-SA-0212, 108 pp.
14. ANSES (Agence nationale de sécurité sanitaire de l'alimentation), 2014. AVIS de l'Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail relatif aux risques liés à la présence dans les compléments alimentaires de p-synéphrine ou d'ingrédients obtenus à partir de fruits de Citrus spp. en contenant. Saisine no 2012-SA-0200.
15. Arab L, Liu W and Elashoff D, 2009. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke, 40, 1786–1792.
16. Aranda JV, Collinge JM, Zinman R and Watters G, 1979. Maturation of caffeine elimination in infancy. Archives of Disease in Childhood, 54, 946–949.
17. Arciero PJ, Gardner AW, Benowitz NL and Poehlman ET, 1998. Relationship of blood pressure, heart rate and behavioral mood state to norepinephrine kinetics in younger and older men following caffeine ingestion. European Journal of Clinical Nutrition, 52, 805–812.
18. Arciero PJ and Ormsbee MJ, 2009. Relationship of blood pressure, behavioral mood state, and physical activity following caffeine ingestion in younger and older women. Applied Physiology, Nutrition, and Metabolism, 34, 754–762.
19. Armstrong LE, 2002. Caffeine, body fluid-electrolyte balance, and exercise performance. International Journal of Sport Nutrition and Exercise Metabolism, 12, 189–206.
20. Armstrong LE, Pumerantz AC, Roti MW, Judelson DA, Watson G, Dias JC, Sokmen B, Casa DJ, Maresh CM, Lieberman H and Kellogg M, 2005. Fluid, electrolyte, and renal indices of hydration during 11 days of controlled caffeine consumption. International Journal of Sport Nutrition and Exercise Metabolism, 15, 252–265.
21. Arnaud M, 1993. Metabolism of caffeine and other components of coffee. In: Caffeine, coffee and health. Ed Garattini S. Raven Press, New York, NY, USA, 43–95.
22. Aronsen L, Orvoll E, Lysaa R, Ravna AW and Sager G, 2014. Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors. European Journal of Pharmacology, 745, 249–253.
23. Astorino TA, Rohmann RL, Firth K and Kelly S, 2007. Caffeine-induced changes in cardiovascular function during resistance training. International Journal of Sport Nutrition and Exercise Metabolism, 17, 468–477.
24. Astorino TA, Martin BJ, Schachtsiek L and Wong K, 2013. Caffeine ingestion and intense resistance training minimize postexercise hypotension in normotensive and prehypertensive men. Research in Sports Medicine, 21, 52–65.
25. Attwood AS, Rogers PJ, Ataya AF, Adams S and Munafo MR, 2012. Effects of caffeine on alcohol-related changes in behavioural control and perceived intoxication in light caffeine consumers. Psychopharmacology, 221, 551–560.
26. Azcona O, Barbanoj MJ, Torrent J and Jane F, 1995. Evaluation of the central effects of alcohol and caffeine interaction. British Journal of Clinical Pharmacology, 40, 393–400.
27. Baer RA, 1987. Effects of caffeine on classroom behavior, sustained attention, and a memory task in preschool children. Journal of Applied Behavior Analysis, 20, 225–234.
28. Bak AA and Grobbee DE, 1990. A randomized study on coffee and blood pressure. Journal of Human Hypertension, 4, 259–264.
29. Bak AA and Grobbee DE, 1991. Caffeine, blood pressure, and serum lipids. American Journal of Clinical Nutrition, 53, 971–975.
30. Bakker R, Steegers EA, Obradov A, Raat H, Hofman A and Jaddoe VW, 2010. Maternal caffeine intake from coffee and tea, fetal growth, and the risks of adverse birth outcomes: the Generation R Study. American Journal of Clinical Nutrition, 91, 1691–1698.
31. Balogh A, Klinger G, Henschel L, Borner A, Vollanth R and Kuhnz W, 1995. Influence of ethinylestradiol-containing combination oral contraceptives with gestodene or levonorgestrel on caffeine elimination. European Journal of Clinical Pharmacology, 48, 161–166.
32. Baylin A, Hernandez-Diaz S, Kabagambe EK, Siles X and Campos H, 2006. Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction. Epidemiology, 17, 506–511.
33. Bech BH, Obel C, Henriksen TB and Olsen J, 2007. Effect of reducing caffeine intake on birth weight and length of gestation: randomised controlled trial. British Medical Journal, 334, 409.
34. Benson S, Verster JC, Alford C and Scholey A, 2014. Effects of mixing alcohol with caffeinated beverages on subjective intoxication: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 47C, 16–21.
35. Bernstein GA, Carroll ME, Crosby RD, Perwien AR, Go FS and Benowitz NL, 1994. Caffeine effects on learning, performance, and anxiety in normal school-age children. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 407–415.
36. Bernstein GA, Carroll ME, Thuras PD, Cosgrove KP and Roth ME, 2002. Caffeine dependence in teenagers. Drug and Alcohol Dependence, 66, 1–6.
37. Berthou F, Flinois JP, Ratanasavanh D, Beaune P, Riche C and Guillouzo A, 1991. Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 19, 561–567.
38. Bertoia ML, Triche EW, Michaud DS, Baylin A, Hogan JW, Neuhouser ML, Freiberg MS, Allison MA, Safford MM, Li WJ, Mossavar-Rahmani Y, Rosal MC and Eaton CB, 2013. Long-term alcohol and caffeine intake and risk of sudden cardiac death in women. American Journal of Clinical Nutrition, 97, 1356–1363.
39. BfR (Bundesinstitut für Risikobewertung), 2008. New Human Data on the Assessment of Energy Drinks. BfR Information No 016/2008.
40. BfR (Bundesinstitut für Risikobewertung), 2009. Gesundheitliche Risiken durch den übermäßigen Verzehr von Energy Shots. Stellungnahme Nr 001/2010 des BfR.
41. BfR (Bundesinstitut für Risikobewertung), 2012. Health assessment of sports and weight loss products containing synephrine and caffeine. BfR Opinion No 004/2013, of 16 November 2012.
42. Bidel S, Hu G, Qiao Q, Jousilahti P, Antikainen R and Tuomilehto J, 2006. Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. Diabetologia, 49, 2618–2626.
43. Blanchard J and Sawers SJ, 1983. The absolute bioavailability of caffeine in man. European Journal of Clinical Pharmacology, 24, 93–98.
44. Bonati M, Latini R, Galletti F, Young JF, Tognoni G and Garattini S, 1982. Caffeine disposition after oral doses. Clinical Pharmacology and Therapeutics, 32, 98–106.
45. Boylan SM, Greenwood DC, Alwan N, Cooke MS, Dolby VA, Hay AW, Kirk SF, Konje JC, Potdar N, Shires S, Simpson NA, Taub N, Thomas JD, Walker JJ, White KL, Wild CP and Cade JE, 2013. Does nausea and vomiting of pregnancy play a role in the association found between maternal caffeine intake and fetal growth restriction? Maternal and Child Health Journal, 17, 601–608.
46. Bui LT, Nguyen DT and Ambrose PJ, 2006. Blood pressure and heart rate effects following a single dose of bitter orange. Annals of Pharmacotherapy, 40, 53–57.
47. Bull S, Brown T, Burnett K, Ashdown L and Rushton L, 2014. Extensive literature search as preparatory work for the safety assessment for caffeine. EFSA supporting publication 2014:EN-561, 98 pp.
48. Burr ML, Gallacher JE, Butland BK, Bolton CH and Downs LG, 1989. Coffee, blood pressure and plasma lipids: a randomized controlled trial. European Journal of Clinical Nutrition, 43, 477–483.
49. Buscemi S, Verga S, Batsis JA, Donatelli M, Tranchina MR, Belmonte S, Mattina A, Re A and Cerasola G, 2010. Acute effects of coffee on endothelial function in healthy subjects. European Journal of Clinical Nutrition, 64, 483–489.
50. Buscemi S, Mattina A, Tranchina MR and Verga S, 2011. Acute effects of coffee on QT interval in healthy subjects. Nutrition Journal, 10, 15.
51. Byrne EM, Johnson J, McRae AF, Nyholt DR, Medland SE, Gehrman PR, Heath AC, Madden PAF, Montgomery GW, Chenevix-Trench G and Martin NG, 2012. A genome-wide association study of caffeine-related sleep disturbance: confirmation of a role for a common variant in the adenosine receptor. Sleep, 35, 967–975.
52. Caldeira D, Martins C, Alves LB, Pereira H, Ferreira JJ and Costa J, 2013. Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies. Heart, 99, 1383–1389.
53. CARE Study Group, 2008. Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. British Medical Journal, 337, a2332.
54. Carrillo JA and Benitez J, 2000. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clinical Pharmacokinetics, 39, 127–153.
55. Cheng M, Hu Z, Lu X, Huang J and Gu D, 2014. Caffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies. Canadian Journal of Cardiology, 30, 448–454.
56. Cheuvront SN, Ely BR, Kenefick RW, Michniak-Kohn BB, Rood JC and Sawka MN, 2009. No effect of nutritional adenosine receptor antagonists on exercise performance in the heat. American Journal of Physiology Regulatory Integrative and Comparative Physiology, 296, R394–401.
57. Childs E and De Wit H, 2006. Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users. Psychopharmacology (Berl), 185, 514–523.
58. Childs E, Hohoff C, Deckert J, Xu K, Badner J and De Wit H, 2008. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology, 33, 2791–2800.
59. Conen D, Chiuve SE, Everett BM, Zhang SM, Buring JE and Albert CM, 2010. Caffeine consumption and incident atrial fibrillation in women. American Journal of Clinical Nutrition, 92, 509–514.
60. Cornelis MC, El-Sohemy A, Kabagambe EK and Campos H, 2006. Coffee, CYP1A2 genotype, and risk of myocardial infarction. Journal of the American Medical Association, 295, 1135–1141.
61. COT (Committee on toxicity of chemicals in food, consumer products and the environment), 2008. Reproductive effects of caffeine.
62. COT (Committee on toxicity of chemicals in food, consumer products and the environment), 2012. COT statement on the interaction of caffeine and alcohol and their combined effects on health and behaviour.
63. DaCosta LA, 2011. Genetic modifiers of caffeine consumption and risk of myocardial infarction. PhD Thesis, University of Toronto, Toronto, ON, Canada.
64. Davis RE and Osorio I, 1998. Childhood caffeine tic syndrome. Pediatrics, 101, E4.
65. De Koning Gans JM, Uiterwaal CS, Van der Schouw YT, Boer JM, Grobbee DE, Verschuren WM and Beulens JW, 2010. Tea and coffee consumption and cardiovascular morbidity and mortality. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 1665–1671.
66. Del Coso J, Estevez E and Mora-Rodriguez R, 2008. Caffeine effects on short-term performance during prolonged exercise in the heat. Medicine and Science in Sports and Exercise, 40, 744–751.
67. Ding M, Bhupathiraju SN, Satija A, Van Dam RM and Hu FB, 2014. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose–response meta-analysis of prospective cohort studies. Circulation, 129, 643–659.
68. Djordjevic N, Ghotbi R, Jankovic S and Aklillu E, 2010. Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2-163C>A polymorphism. European Journal of Clinical Pharmacology, 66, 697–703.
69. Dobmeyer DJ, Stine RA, Leier CV, Greenberg R and Schaal SF, 1983. The arrhythmogenic effects of caffeine in human beings. New England Journal of Medicine, 308, 814–816.
70. Doherty M and Smith PM, 2005. Effects of caffeine ingestion on rating of perceived exertion during and after exercise: a meta-analysis. Scandinavian Journal of Medicine & Science in Sports, 15, 69–78.
71. Dorfman LJ and Jarvik ME, 1970. Comparative stimulant and diuretic actions of caffeine and theobromine in man. Clinical Pharmacology and Therapeutics, 11, 869–872.
72. Driessen MT, Koppes LL, Veldhuis L, Samoocha D and Twisk JW, 2009. Coffee consumption is not related to the metabolic syndrome at the age of 36 years: the Amsterdam Growth and Health Longitudinal Study. European Journal of Clinical Nutrition, 63, 536–542.
73. EFSA (European Food Safety Authority), 2009. Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food (ANS) on a request from the European Commission on the use of taurine and D-glucurono-γ-lactone as constituents of the so-called “energy” drinks. The EFSA Journal 2009, 935, 1–31.
74. EFSA (European Food Safety Authority), 2011a. Scientific report on the Evaluation of the FoodEx, the food classification system applied to the development of the EFSA Comprehensive European Food Consumption Database. EFSA Journal 2011;9(3):1970, 27 pp. doi:10.2903/j.efsa.2011.1970.
75. EFSA (European Food Safety Authority), 2011b. Guidance of EFSA on the use of the EFSA Comprehensive European Food Consumption Database in Intakes Assessment. EFSA Journal 2011;9(3):2097, 34 pp. doi:10.2903/j.efsa.2011.2097.
76. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2011a. Scientific Opinion on the substantiation of health claims related to caffeine and increase in physical performance during short-term high-intensity exercise (ID 737, 1486, 1489), increase in endurance performance (ID 737, 1486), increase in endurance capacity (ID 1488) and reduction in the rated perceived exertion/effort during exercise (ID 1488, 1490) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2011;9(4):2053, 24 pp, doi:10.2903/j.efsa.2011.2053.
77. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2011b. Scientific Opinion on the substantiation of health claims related to caffeine and increased fat oxidation leading to a reduction in body fat mass (ID 735, 1484), increased energy expenditure leading to a reduction in body weight (ID 1487), increased alertness (ID 736, 1101, 1187, 1485, 1491, 2063, 2103) and increased attention (ID 736, 1485, 1491, 2375) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2011;9(4):2054, 29 pp. doi:10.2903/j.efsa.2011.2054.
78. Eggertsen R, Andreasson A, Hedner T, Karlberg BE and Hansson L, 1993. Effect of coffee on ambulatory blood pressure in patients with treated hypertension. Journal of Internal Medicine, 233, 351–355.
79. Elkins RN, Rapoport JL, Zahn TP, Buchsbaum MS, Weingartner H, Kopin IJ, Langer D and Johnson C, 1981. Acute effects of caffeine in normal prepubertal boys. American Journal of Psychiatry, 138, 178–183.
80. Ely BR, Ely MR and Cheuvront SN, 2011. Marginal effects of a large caffeine dose on heat balance during exercise-heat stress. International Journal of Sport Nutrition and Exercise Metabolism, 21, 65–70.
81. Evira, 2013. Food supplements containing synephrine and caffeine withdrawn from sale. 06.09.2013, 15, 22.
82. Farag NH, Vincent AS, McKey BS, Whitsett TL and Lovallo WR, 2005a. Hemodynamic mechanisms underlying the incomplete tolerance to caffeine's pressor effects. American Journal of Cardiology, 95, 1389–1392.
83. Farag NH, Vincent AS, Sung BH, Whitsett TL, Wilson MF and Lovallo WR, 2005b. Caffeine tolerance is incomplete: Persistent blood pressure responses in the ambulatory setting. American Journal of Hypertension, 18, 714–719.
84. Farag NH, Whitsett TL, McKey BS, Wilson MF, Vincent AS, Everson-Rose SA and Lovallo WR, 2010. Caffeine and blood pressure response: sex, age, and hormonal status. Journal of Womens Health, 19, 1171–1176.
85. Fenster L, Quale C, Hiatt RA, Wilson M, Windham GC and Benowitz NL, 1998. Rate of caffeine metabolism and risk of spontaneous abortion. American Journal of Epidemiology, 147, 503–510.
86. Ferre S, 2008. An update on the mechanisms of the psychostimulant effects of caffeine. Journal of Neurochemistry, 105, 1067–1079.
87. Ferreira SE, De Mello MT, Pompeia S and De Souza-Formigoni ML, 2006. Effects of energy drink ingestion on alcohol intoxication. Alcoholism, Clinical and Experimental Research, 30, 598–605.
88. Fillmore MT and Vogel-Sprott M, 1999. An alcohol model of impaired inhibitory control and its treatment in humans. Experimental and Clinical Psychopharmacology, 7, 49–55.
89. Fillmore MT, Roach EL and Rice JT, 2002. Does caffeine counteract alcohol-induced impairment? The ironic effects of expectancy. Journal of Studies on Alcohol, 63, 745–754.
90. Fisone G, Borgkvist A and Usiello A, 2004. Caffeine as a psychomotor stimulant: mechanism of action. Cellular and Molecular Life Sciences, 61, 857–872.
91. Fitt E, Pell D and Cole D, 2013. Assessing caffeine intake in the United Kingdom diet. Food Chemistry, 140, 421–426.
92. Floegel A, Pischon T, Bergmann MM, Teucher B, Kaaks R and Boeing H, 2012. Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study. American Journal of Clinical Nutrition, 95, 901–908.
93. Franks AM, Schmidt JM, McCain KR and Fraer M, 2012. Comparison of the effects of energy drink versus caffeine supplementation on indices of 24-hour ambulatory blood pressure. Annals of Pharmacotherapy, 46, 192–199.
94. Fredholm BB, Bättig K, Holmén J, Nehlig A and Zvartau EE, 1999. Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use. Pharmacological Reviews, 51, 83–133.
95. Freedman ND, Park Y, Abnet CC, Hollenbeck AR and Sinha R, 2012. Association of coffee drinking with total and cause-specific mortality. New England Journal of Medicine, 366, 1891–1904.
96. Frost L and Vestergaard P, 2005. Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. American Journal of Clinical Nutrition, 81, 578–582.
97. FSANZ (Food Standards Australia New Zealand), 2000. Report from the expert working group on the safety aspects of dietary caffeine.
98. Funatsu K, Yamashita T and Nakamura H, 2005. Effect of coffee intake on blood pressure in male habitual alcohol drinkers. Hypertension Research, 28, 521–527.
99. Gaemperli O, Schepis T, Koepfli P, Siegrist PT, Fleischman S, Nguyen P, Olmsted A, Wang W, Lieu H and Kaufmann PA, 2008. Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial. Journal of the American College of Cardiology, 51, 328–329.
100. Ghotbi R, Christensen M, Roh HK, Ingelman-Sundberg M, Aklillu E and Bertilsson L, 2007. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype–phenotype relationship in Swedes and Koreans. European Journal of Clinical Pharmacology, 63, 537–546.
101. Giggey PP, Wendell CR, Zonderman AB and Waldstein SR, 2011. Greater coffee intake in men is associated with steeper age-related increases in blood pressure. American Journal of Hypertension, 24, 310–315.
102. Ginsberg G, Hattis D, Russ A and Sonawane B, 2004. Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents. Journal of Toxicology and Environmental Health, Part A, 67, 297–329.
103. Goldstein A and Wallace ME, 1997. Caffeine dependence in schoolchildren? Experimental and Clinical Psychopharmacology, 5, 388–392.
104. Gougeon R, Harrigan K, Tremblay JF, Hedrei P, Lamarche M and Morais JA, 2005. Increase in the thermic effect of food in women by adrenergic amines extracted from citrus aurantium. Obesity Research, 13, 1187–1194.
105. Grasser E, Yepuri G, Dulloo A and Montani J-P, 2014. Cardio- and cerebrovascular responses to the energy drink Red Bull in young adults: a randomized cross-over study. European Journal of Nutrition, 53, 1–71.
106. Greenberg JA, Dunbar CC, Schnoll R, Kokolis R, Kokolis S and Kassotis J, 2007. Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis. American Journal of Clinical Nutrition, 85, 392–398.
107. Greenberg JA, Chow G and Ziegelstein RC, 2008. Caffeinated coffee consumption, cardiovascular disease, and heart valve disease in the elderly (from the Framingham Study). American Journal of Cardiology, 102, 1502–1508.
108. Greenland S, 1993. A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology, 4, 366–374.
109. Greenwood DC, Alwan N, Boylan S, Cade JE, Charvill J, Chipps KC, Cooke MS, Dolby VA, Hay AW, Kassam S, Kirk SF, Konje JC, Potdar N, Shires S, Simpson N, Taub N, Thomas JD, Walker J, White KL and Wild CP, 2010. Caffeine intake during pregnancy, late miscarriage and stillbirth. European Journal of Epidemiology, 25, 275–280.
110. Grobbee DE, Rimm EB, Giovannucci E, Colditz G, Stampfer M and Willett W, 1990. Coffee, caffeine, and cardiovascular disease in men. New England Journal of Medicine, 323, 1026–1032.
111. Grosso LM, Triche EW, Belanger K, Benowitz NL, Holford TR and Bracken MB, 2006. Caffeine metabolites in umbilical cord blood, cytochrome P-450 1A2 activity, and intrauterine growth restriction. American Journal of Epidemiology, 163, 1035–1041.
112. Gyntelberg F, Hein HO, Suadicani P and Sorensen H, 1995. Coffee consumption and risk of ischaemic heart disease–a settled issue? Journal of Internal Medicine, 237, 55–61.
113. Hakim AA, Ross GW, Curb JD, Rodriguez BL, Burchfiel CM, Sharp DS, Yano K and Abbott RD, 1998. Coffee consumption in hypertensive men in older middle-age and the risk of stroke: The Honolulu Heart Program. Journal of Clinical Epidemiology, 51, 487–494.
114. Hale KL, Hughes JR, Oliveto AH and Higgins ST, 1995. Caffeine self-administration and subjective effects in adolescents. Experimental and Clinical Pharmacology, 3, 364–370.
115. Haller CA, Benowitz NL and Jacob P 3rd, 2005a. Hemodynamic effects of ephedra-free weight-loss supplements in humans. American Journal of Medicine, 118, 998–1003.
116. Haller CA, Jacob P and Benowitz NL, 2005b. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations. Clinical Pharmacology and Therapeutics, 77, 560–571.
117. Haller CA, Duan M, Jacob P 3rd and Benowitz N, 2008. Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions. British Journal of Clinical Pharmacology, 65, 833–840.
118. Han XM, Ou-Yang DS, Lu PX, Jiang CH, Shu Y, Chen XP, Tan ZR and Zhou HH, 2001. Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2. Pharmacogenetics, 11, 429–435.
119. Happonen P, Voutilainen S and Salonen JT, 2004. Coffee drinking is dose-dependently related to the risk of acute coronary events in middle-aged men. The Journal of Nutrition, 134, 2381–2386.
120. Happonen P, Laara E, Hiltunen L and Luukinen H, 2008. Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population. British Journal of Nutrition, 99, 1354–1361.
121. Hart C and Smith GD, 1997. Coffee consumption and coronary heart disease mortality in Scottish men: a 21 year follow up study. Journal of Epidemiology and Community Health, 51, 461–462.
122. Hartley TR, Sung BH, Pincomb GA, Whitsett TL, Wilson MF and Lovallo WR, 2000. Hypertension risk status and effect of caffeine on blood pressure. Hypertension, 36, 137–141.
123. Hartley TR, Lovallo WR and Whitsett TL, 2004. Cardiovascular effects of caffeine in men and women. American Journal of Cardiology, 93, 1022–1026.
124. Health Canada, 2006. It's your health. Caffeine. Available online: http://publications.gc.ca/collections/collection_2007/hc-sc/H13-7-2-2006E.pdf.
125. Health Canada, 2011. Synephrine, Octopamine and Caffeine Health Risk Assessment (HRA) Report. Health Canada File No 172091.
126. Heatherley SV, Hancock KM and Rogers PJ, 2006. Psychostimulant and other effects of caffeine in 9-to 11-year-old children. Journal of Child Psychology and Psychiatry, 47, 135–142.
127. Heckman MA, Weil J and Gonzalez de Mejia E, 2010. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. Journal of Food Science, 75, R77–87.
128. Heinz AJ, De Wit H, Lilje TC and Kassel JD, 2013. The combined effects of alcohol, caffeine, and expectancies on subjective experience, impulsivity, and risk-taking. Experimental and Clinical Psychopharmacology, 21, 222–234.
129. Henzlova MJ, Cerqueira MD, Mahmarian JJ, Yao SS and Quality Assurance Committee of the American Society of Nuclear C, 2006. Stress protocols and tracers. Journal of Nuclear Cardiology, 13, e80–90.
130. Higgins JP and Babu KM, 2013. Caffeine reduces myocardial blood flow during exercise. American Journal of Medicine, 126, 730 e731–738.
131. Hildebrandt R and Gundert-Remy U, 1983. Lack of pharmacological active saliva levels of caffeine in breast-fed infants. Pediatric Pharmacology, 3, 237–244.
132. Hodgson JM, Puddey IB, Burke V, Beilin LJ and Jordan N, 1999. Effects on blood pressure of drinking green and black tea. Journal of Hypertension, 17, 457–463.
133. Hofer I and Battig K, 1994. Cardiovascular, behavioral, and subjective effects of caffeine under field conditions. Pharmacology, Biochemistry and Behavior, 48, 899–908.
134. Howland J, Rohsenow DJ, Arnedt JT, Bliss CA, Hunt SK, Calise TV, Heeren T, Winter M, Littlefield C and Gottlieb DJ, 2011. The acute effects of caffeinated versus non-caffeinated alcoholic beverage on driving performance and attention/reaction time. Addiction, 106, 335–341.
135. Hu G, Jousilahti P, Nissinen A, Bidel S, Antikainen R and Tuomilehto J, 2007. Coffee consumption and the incidence of antihypertensive drug treatment in Finnish men and women. American Journal of Clinical Nutrition, 86, 457–464.
136. Huybrechts I, Sioen I, Boon PE, Ruprich J, Lafay L, Turrini A, Amiano P, Hirvonen T, De Neve M, Arcella D, Moschandreas J, Westerlund A, Ribas-Barba L, Hilbig A, Papoutsou S, Christensen T, Oltarzewski M, Virtanen S, Rehurkova I, Azpiri M, Sette S, Kersting M, Walkiewicz A, Serra-Majem L, Volatier JL, Trolle E, Tornaritis M, Busk L, Kafatos A, Fabiansson S, De Henauw S and Van Klaveren JD, 2011. Dietary exposure assessments for children in europe (the EXPOCHI project): rationale, methods and design. Archives of Public Health, 69, 4.
137. Infante-Rivard C, 2007. Caffeine intake and small-for-gestational-age birth: modifying effects of xenobiotic-metabolising genes and smoking. Paediatric and Perinatal Epidemiology, 21, 300–309.
138. Jacobsen BK, Bjelke E, Kvale G and Heuch I, 1986. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. Journal of the National Cancer Institute, 76, 823–831.
139. Jahanfar S and Sharifah H, 2009. Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcome. Cochrane Database Systematic Reviews, CD006965.
140. Jahanfar S and Jaafar SH, 2013. Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcome. Cochrane database of systematic reviews (Online), 2, CD006965.
141. James JE, 1994. Chronic effects of habitual caffeine consumption on laboratory and ambulatory blood pressure levels. Journal of Cardiovascular Risk, 1, 159–164.
142. Jazbec A, Simic D, Corovic N, Durakovic Z and Pavlovic M, 2003. Impact of coffee and other selected factors on general mortality and mortality due to cardiovascular disease in Croatia. Journal of Health, Population and Nutrition, 21, 332–340.
143. Jee SH, He J, Whelton PK, Suh I and Klag MJ, 1999. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension, 33, 647–652.
144. Jenner DA, Puddey IB, Beilin LJ and Vandongen R, 1988. Lifestyle- and occupation-related changes in blood pressure over a six-year period in a cohort of working men. Journal of Hypertension. Supplement, 6, S605–607.
145. Joeres R, Klinker H, Heusler H, Epping J, Zilly W and Richter E, 1988. Influence of smoking on caffeine elimination in healthy volunteers and in patients with alcoholic liver cirrhosis. Hepatology, 8, 575–579.
146. Juliano LM and Griffiths RR, 2004. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl), 176, 1–29.
147. Kaats GR, Miller H, Preuss HG and Stohs SJ, 2013. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract. Food and Chemical Toxicology, 55, 358–362.
148. Kalman DS, Oxford S, Schwartz HI and Krieger DR, 2002. A double blind clinical evaluation of the metabolic effects of Xenadrine EFXTM compared to two ephedra-containing products in normal healthy volunteers. Presented at the annual meeting of the American College of Nutrition, Abstract No. 101. Journal of the American College of Nutrition, 21, 488.
149. Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS and Shader RI, 1997. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. Journal of Clinical Pharmacology, 37, 693–703.
150. Karatzis E, Papaioannou TG, Aznaouridis K, Karatzi K, Stamatelopoulos K, Zampelas A, Papamichael C, Lekakis J and Mavrikakis M, 2005. Acute effects of caffeine on blood pressure and wave reflections in healthy subjects: should we consider monitoring central blood pressure? International Journal of Cardiology, 98, 425–430.
151. Kario K, 2010. Morning surge in blood pressure and cardiovascular risk: evidence and perspectives. Hypertension, 56, 765–773.
152. Karypidis AH, Soderstrom T, Nordmark A, Granath F, Cnattingius S and Rane A, 2006. Association of cytochrome P450 1B1 polymorphism with first-trimester miscarriage. Fertility and Sterility, 86, 1498–1503.
153. Kawachi I, Colditz GA and Stone CB, 1994. Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. British Heart Journal, 72, 269–275.
154. Killer SC, Blannin AK and Jeukendrup AE, 2014. No evidence of dehydration with moderate daily coffee intake: a counterbalanced cross-over study in a free-living population. PLOS ONE, 9, e84154.
155. Kim B, Nam Y, Kim J, Choi H and Won C, 2012. Coffee consumption and stroke risk: A meta-analysis of epidemiologic studies. Korean Journal of Family Medicine, 33, 356–365.
156. Kim TW, Shin YO, Lee JB, Min YK and Yang HM, 2011. Caffeine increases sweating sensitivity via changes in sudomotor activity during physical loading. Journal of Medicinal Food, 14, 1448–1455.
157. Kirkinen P, Jouppila P, Koivula A, Vuori J and Puukka M, 1983. The effect of caffeine on placental and fetal blood flow in human pregnancy. American Journal of Obstetrics and Gynecology, 147, 939–942.
158. Klag MJ, Mead LA, LaCroix AZ, Wang NY, Coresh J, Liang KY, Pearson TA and Levine DM, 1994. Coffee intake and coronary heart disease. Annals of Epidemiology, 4, 425–433.
159. Klag MJ, Wang NY, Meoni LA, Brancati FL, Cooper LA, Liang KY, Young JH and Ford DE, 2002. Coffee intake and risk of hypertension: the Johns Hopkins precursors study. Archives of Internal Medicine, 162, 657–662.
160. Klatsky AL, Friedman GD and Armstrong MA, 1990. Coffee use prior to myocardial infarction restudied: heavier intake may increase the risk. American Journal of Epidemiology, 132, 479–488.
161. Klatsky AL, Armstrong MA and Friedman GD, 1993. Coffee, tea, and mortality. Annals of Epidemiology, 3, 375–381.
162. Klatsky AL, Hasan AS, Armstrong MA, Udaltsova N and Morton C, 2011. Coffee, caffeine, and risk of hospitalization for arrhythmias. The Permanente Journal, 15, 19–25.
163. Kleemola P, Jousilahti P, Pietinen P, Vartiainen E and Tuomilehto J, 2000. Coffee consumption and the risk of coronary heart disease and death. Archives of Internal Medicine, 160, 3393–3400.
164. Knutti R, Rothweiler H and Schlatter C, 1981. Effect of pregnancy on the pharmacokinetics of caffeine. European Journal of Clinical Pharmacology, 21, 121–126.
165. Knutti R, Rothweiler H and Schlatter C, 1982. The effect of pregnancy on the pharmacokinetics of caffeine. Archives of Toxicology Supplement, 5, 187–192.
166. Kokubo Y, Iso H, Saito I, Yamagishi K, Yatsuya H, Ishihara J, Inoue M and Tsugane S, 2013. The impact of green tea and coffee consumption on the reduced risk of stroke incidence in Japanese population: the Japan public health center-based study cohort. Stroke, 44, 1369–1374.
167. LaCroix AZ, Mead LA, Liang KY, Thomas CB and Pearson TA, 1986. Coffee consumption and the incidence of coronary heart disease. New England Journal of Medicine, 315, 977–982.
168. Landolt HP, Dijk DJ, Gaus SE and Borbely AA, 1995. Caffeine reduces low-frequency delta activity in the human sleep EEG. Neuropsychopharmacology, 12, 229–238.
169. Lane JD, Pieper CF, Phillips-Bute BG, Bryant JE and Kuhn CM, 2002. Caffeine affects cardiovascular and neuroendocrine activation at work and home. Psychosomatic Medicine, 64, 595–603.
170. Larsson SC, Mannisto S, Virtanen MJ, Kontto J, Albanes D and Virtamo J, 2008. Coffee and tea consumption and risk of stroke subtypes in male smokers. Stroke, 39, 1681–1687.
171. Larsson SC and Orsini N, 2011. Coffee consumption and risk of stroke: a dose–response meta-analysis of prospective studies. American Journal of Epidemiology, 174, 993–1001.
172. Larsson SC, Virtamo J and Wolk A, 2011. Coffee consumption and risk of stroke in women. Stroke, 42, 908–912.
173. LeGrady D, Dyer AR, Shekelle RB, Stamler J, Liu K, Paul O, Lepper M and Shryock AM, 1987. Coffee consumption and mortality in the Chicago Western Electric Company Study. American Journal of Epidemiology, 126, 803–812.
174. Leurs LJ, Schouten LJ, Goldbohm RA and Van den Brandt PA, 2010. Total fluid and specific beverage intake and mortality due to IHD and stroke in the Netherlands Cohort Study. British Journal of Nutrition, 104, 1212–1221.
175. Levitan EB, Ahmed HN, Mittleman MA and Wolk A, 2011. Coffee consumption and incidence of heart failure in women. Circulation: Heart Failure, 4, 414–418.
176. Leviton A, 1992. Behavioral correlates of caffeine consumption by children. Clinical Pediatrics, 31, 742–750.
177. Liguori A and Robinson JH, 2001. Caffeine antagonism of alcohol-induced driving impairment. Drug and Alcohol Dependence, 63, 123–129.
178. Lindsted KD, Kuzma JW and Anderson JL, 1992. Coffee consumption and cause-specific mortality. Association with age at death and compression of mortality. Journal of Clinical Epidemiology, 45, 733–742.
179. Loomba RS, Aggarwal S and Arora RR, 2014. The effect of coffee and quantity of consumption on specific cardiovascular and all-cause mortality: coffee consumption does not affect mortality. American Journal of Therapeutics. doi: 10.1097/MJT.0000000000000099.
180. Lopez-Garcia E, Van Dam RM, Willett WC, Rimm EB, Manson JE, Stampfer MJ, Rexrode KM and Hu FB, 2006. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation, 113, 2045–2053.
181. Lopez-Garcia E, Rodriguez-Artalejo F, Rexrode KM, Logroscino G, Hu FB and Van Dam RM, 2009. Coffee consumption and risk of stroke in women. Circulation, 119, 1116–1123.
182. MacDonald TM, Sharpe K, Fowler G, Lyons D, Freestone S, Lovell HG, Webster J and Petrie JC, 1991. Caffeine restriction: effect on mild hypertension. British Medical Journal, 303, 1235–1238.
183. Maclure M, 1991. The case-crossover design: a method for studying transient effects on the risk of acute events. American Journal of Epidemiology, 133, 144–153.
184. Mahmud A and Feely J, 2001. Acute effect of caffeine on arterial stiffness and aortic pressure waveform. Hypertension, 38, 227–231.
185. Marczinski CA and Fillmore MT, 2003. Dissociative antagonistic effects of caffeine on alcohol-induced impairment of behavioral control. Experimental and Clinical Psychopharmacology, 11, 228–236.
186. Marczinski CA and Fillmore MT, 2006. Clubgoers and their trendy cocktails: Implications of mixing caffeine into alcohol on information processing and subjective reports of intoxication. Experimental and Clinical Psychopharmacology, 14, 450–458.
187. Marczinski CA, Fillmore MT, Bardgett ME and Howard MA, 2011. Effects of energy drinks mixed with alcohol on behavioral control: risks for college students consuming trendy cocktails. Alcoholism, Clinical and Experimental Research, 35, 1282–1292.
188. Marczinski CA, Fillmore MT, Henges AL, Ramsey MA and Young CR, 2012. Effects of energy drinks mixed with alcohol on information processing, motor coordination and subjective reports of intoxication. Experimental and Clinical Psychopharmacology, 20, 129–138.
189. Marczinski CA, Fillmore MT, Henges AL, Ramsey MA and Young CR, 2013. Mixing an energy drink with an alcoholic beverage increases motivation for more alcohol in college students. Alcoholism, Clinical and Experimental Research, 37, 276–283.
190. Martin JB, Annegers JF, Curb JD, Heyden S, Howson C, Lee ES and Lee M, 1988. Mortality patterns among hypertensives by reported level of caffeine consumption. Preventive Medicine, 17, 310–320.
191. Martindale RG, Mccarthy MS and Mcclave SA, 2011. Guidelines for nutrition therapy in critical illness: are not they all the same? Minerva Anestesiologica, 77, 463–467.
192. Mattioli AV, Bonatti S, Zennaro M and Mattioli G, 2005. The relationship between personality, socio-economic factors, acute life stress and the development, spontaneous conversion and recurrences of acute lone atrial fibrillation. Europace, 7, 211–220.
193. Mayo Clinic Staff, 2013. Caffeine content for coffee, tea, soda and more. Available online: http://www.mayoclinic.org/healthy-living/nutrition-and-healthy-eating/in-depth/caffeine/art-20049372. Accessed June 2014.
194. McCall DO, McKinley MC, Noad R, McKeown PP, McCance DR, Young IS and Woodside JV, 2011. The assessment of vascular function during dietary intervention trials in human subjects. British Journal of Nutrition, 106, 981–994.
195. McMahon G, Taylor AE, Davey Smith G and Munafo MR, 2014. Phenotype Refinement Strengthens the Association of AHR and CYP1A1 Genotype with Caffeine Consumption. PLOS ONE, 9, e103448.
196. Merten C, Ferrari P, Bakker M, Boss A, Hearty A, Leclercq C, Lindtner O, Tlustos C, Verger P, Volatier JL and Arcella D, 2011. Methodological characteristics of the national dietary surveys carried out in the European Union as included in the European Food Safety Authority (EFSA) Comprehensive European Food Consumption Database. Food Additives and Contaminants. Part A, Chemistry, Analysis, Control, Exposure and Risk Assessment, 28, 975–995.
197. Mesas AE, Leon-Munoz LM, Rodriguez-Artalejo F and Lopez-Garcia E, 2011. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. American Journal of Clinical Nutrition, 94, 1113–1126.
198. MHRA (Regulatory Medicines and Medical Devices), 2012. MHRA warns public of potentially dangerous sports supplements. http://www.mhra.gov.uk/home/groups/comms-po/documents/news/con174847.pdf.
199. Millard-Stafford ML, Cureton KJ, Wingo JE, Trilk J, Warren GL and Buyckx M, 2007. Hydration during exercise in warm, humid conditions: effect of a caffeinated sports drink. International Journal of Sport Nutrition and Exercise Metabolism, 17, 163–177.
200. Min B, Cios D, Kluger J and White CM, 2005. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects. Pharmacotherapy, 25, 1719–1724.
201. Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Kondo T and Tamakoshi A, 2011. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. Journal of Epidemiology and Community Health, 65, 230–240.
202. Miners JO and Birkett DJ, 1996. The use of caffeine as a metabolic probe for human drug metabolizing enzymes. General Pharmacology, 27, 245–249.
203. Ministry of Agriculture, Fisheries and Food, 1998. Survey of caffeine and other methylxanthines in energy drinks and other caffeine-containing products (updated) Food Surveillance Information Sheet 144. http://archive.food.gov.uk/maff/archive/food/infsheet/1998/no144/144caff.htm. Accessed 28.05.2012.
204. Mostofsky E, Schlaug G, Mukamal KJ, Rosamond WD and Mittleman MA, 2010a. Coffee and acute ischemic stroke onset: The Stroke Onset Study. Neurology, 75, 1583–1588.
205. Mostofsky E, Burger MR, Schlaug G, Mukamal KJ, Rosamond WD and Mittleman MA, 2010b. Alcohol and acute ischemic stroke onset: the stroke onset study. Stroke, 41, 1845–1849.
206. Mostofsky E, Rice MS, Levitan EB and Mittleman MA, 2012. Habitual coffee consumption and risk of heart failure a dose-response meta-analysis. Circulation: Heart Failure, 5, 401–405.
207. Mukamal KJ, Hallqvist J, Hammar N, Ljung R, Gemes K, Ahlbom A, Ahnve S and Janszky I, 2009. Coffee consumption and mortality after acute myocardial infarction: The Stockholm Heart Epidemiology Program. American Heart Journal, 157, 495–501.
208. Murray SS, Bjelke E, Gibson RW and Schuman LM, 1981. Coffee consumption and mortality from ischemic heart disease and other causes: results from the Lutheran Brotherhood study, 1966–1978. American Journal of Epidemiology, 113, 661–667.
209. Namdar M, Koepfli P, Grathwohl R, Siegrist PT, Klainguti M, Schepis T, Delaloye R, Wyss CA, Fleischmann SP, Gaemperli O and Kaufmann PA, 2006. Caffeine decreases exercise-induced myocardial flow reserve. Journal of the American College of Cardiology, 47, 405–410.
210. Namdar M, Schepis T, Koepfli P, Gaemperli O, Siegrist PT, Grathwohl R, Valenta I, Delaloye R, Klainguti M, Wyss CA, Luscher TF and Kaufmann PA, 2009. Caffeine impairs myocardial blood flow response to physical exercise in patients with coronary artery disease as well as in age-matched controls. PLOS ONE, 4, e5665.
211. Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtz A and Feeley M, 2003. Effects of caffeine on human health. Food Additives & Contaminants, 20, 1–30.
212. Nickell PV and Uhde TW, 1994. Dose-response effects of intravenous caffeine in normal volunteers. Anxiety, 1, 161–168.
213. NNT (Nordic Working Group on Food Toxicology and Risk Evaluation), 2004. Intake of caffeine and other methylxanthines during pregnancy and risk for adverse effects in pregnant women and their foetuses. TemaNord, 565.
214. NNT (Nordic Working Group on Food Toxicology and Risk Evaluation), 2008. Risk assessment of caffeine among children and adolescents in the Nordic countries. TemaNord, 551.
215. Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE and Geleijnse JM, 2005. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. Journal of Hypertension, 23, 921–928.
216. Nurminen ML, Niittynen L, Korpela R and Vapaatalo H, 1999. Coffee, caffeine and blood pressure: a critical review. European Journal of Clinical Nutrition, 53, 831–839.
217. O'Neil MJ, 2008. The Merck Index – An encyclopedia of chemicals, drugs, and biologicals. Whitehouse Station, NJ, USA, 11625 pp.
218. Palatini P, Dorigatti F, Santonastaso M, Cozzio S, Biasion T, Garavelli G, Pessina AC and Mos L, 2007. Association between coffee consumption and risk of hypertension. Annals of Medicine, 39, 545–553.
219. Palatini P, 2007. Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms. Drugs, 67(Suppl. 2), 3–13.
220. Palatini P, Ceolotto G, Ragazzo F, Dorigatti F, Saladini F, Papparella I, Mos L, Zanata G and Santonastaso M, 2009. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. Journal of Hypertension, 27, 1594–1601.
221. Papamichael CM, Aznaouridis KA, Karatzis EN, Karatzi KN, Stamatelopoulos KS, Vamvakou G, Lekakis JP and Mavrikakis ME, 2005. Effect of coffee on endothelial function in healthy subjects: the role of caffeine. Clinical Science (London), 109, 55–60.
222. Peacock A, Bruno R, Martin FH and Carr A, 2013. The impact of alcohol and energy drink consumption on intoxication and risk-taking behavior. Alcoholism, Clinical and Experimental Research, 37, 1234–1242.
223. Penzak SR, Jann MW, Cold JA, Hon YY, Desai HD and Gurley BJ, 2001. Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults. Journal of Clinical Pharmacology, 41, 1059–1063.
224. Ping WC, Keong CC and Bandyopadhyay A, 2010. Effects of acute supplementation of caffeine on cardiorespiratory responses during endurance running in a hot & humid climate. Indian Journal of Medical Research, 132, 36–41.
225. Pollak CP and Bright D, 2003. Caffeine consumption and weekly sleep patterns in US seventh-, eighth-, and ninth-graders. Pediatrics, 111, 42–46.
226. Rakic V, Burke V and Beilin LJ, 1999. Effects of coffee on ambulatory blood pressure in older men and women: A randomized controlled trial. Hypertension, 33, 869–873.
227. Rapoport JL, Elkins R, Neims A, Zahn T and Berg CJ, 1981a. Behavioral and autonomic effects of caffeine in normal boys. Developmental Pharmacology and Therapeutics, 3, 74–82.
228. Rapoport JL, Jensvold M, Elkins R, Buchsbaum MS, Weingartner H, Ludlow C, Zahn TP, Berg CJ and Neims AH, 1981b. Behavioral and cognitive effects of caffeine in boys and adult males. Journal of Nervous and Mental Disease, 169, 726–732.
229. Rapoport JL, Berg CJ, Ismond DR, Zahn TP and Neims A, 1984. Behavioral effects of caffeine in children. Relationship between dietary choice and effects of caffeine challenge. Archives of General Psychiatry, 41, 1073–1079.
230. Rasmussen BB, Brix TH, Kyvik KO and Brosen K, 2002. The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics, 12, 473–478.
231. Rautiainen S, Levitan EB, Orsini N, Akesson A, Morgenstern R, Mittleman MA and Wolk A, 2012. Total antioxidant capacity from diet and risk of myocardial infarction: a prospective cohort of women. American Journal of Medicine, 125, 974–980.
232. Retey JV, Adam M, Khatami R, Luhmann UF, Jung HH, Berger W and Landolt HP, 2007. A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clinical Pharmacology and Therapeutics, 81, 692–698.
233. Rieg T, Steigele H, Schnermann J, Richter K, Osswald H and Vallon V, 2005. Requirement of intact adenosine A1 receptors for the diuretic and natriuretic action of the methylxanthines theophylline and caffeine. Journal of Pharmacology and Experimental Therapeutics, 313, 403–409.
234. Riesenhuber A, Boehm M, Posch M and Aufricht C, 2006. Diuretic potential of energy drinks. Amino Acids, 31, 81–83.
235. Rietveld EC, Broekman MM, Houben JJ, Eskes TK and Van Rossum JM, 1984. Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids. European Journal of Clinical Pharmacology, 26, 371–373.
236. Robertson D, Frolich JC, Carr RK, Watson JT, Hollifield JW, Shand DG and Oates JA, 1978. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. New England Journal of Medicine, 298, 181–186.
237. Robertson D, Hollister AS, Kincaid D, Workman R, Goldberg MR, Tung CS and Smith B, 1984. Caffeine and hypertension. American Journal of Medicine, 77, 54–60.
238. Rodenburg EM, Eijgelsheim M, Geleijnse JM, Amin N, Van Duijn CM, Hofman A, Uitterlinden AG, Stricker BH and Visser LE, 2012. CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking. American Journal of Clinical Nutrition, 96, 182–187.
239. Roelands B, Buyse L, Pauwels F, Delbeke F, Deventer K and Meeusen R, 2011. No effect of caffeine on exercise performance in high ambient temperature. European Journal of Applied Physiology, 111, 3089–3095.
240. Rogers PJ, Hohoff C, Heatherley SV, Mullings EL, Maxfield PJ, Evershed RP, Deckert J and Nutt DJ, 2010. Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology, 35, 1973–1983.
241. Rosengren A and Wilhelmsen L, 1991. Coffee, coronary heart disease and mortality in middle-aged Swedish men: findings from the Primary Prevention Study. Journal of Internal Medicine, 230, 67–71.
242. Rosmarin PC, Applegate WB and Somes GW, 1990. Coffee consumption and blood pressure: a randomized, crossover clinical trial. Journal of General Internal Medicine, 5, 211–213.
243. Rosner SA, Åkesson A, Stampfer MJ and Wolk A, 2007. Coffee consumption and risk of myocardial infarction among older Swedish women. American Journal of Epidemiology, 165, 288–293.
244. Rotstein J, Barber J, Strowbridge C, Hayward S, Huang R and Godefroy SB, 2013. Energy Drinks: An Assessment of the Potential Health Risks in the Canadian Context. International Food Risk Analysis Journal, 3.
245. Rudolph E, Faerbinger A, Koening J, 2012. Determination of the caffeine contents of various food items within the Austrian market and validation of a caffeine assessment tool (CAT). Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment, 29, 1849–60.
246. Rush CR, Higgins ST, Hughes JR, Bickel WK and Wiegner MS, 1989. Acute behavioral and cardiac effects of alcohol and caffeine, alone and in combination, in humans. Behavioural Pharmacology, 4, 562–572.
247. Sachse C, Brockmoller J, Bauer S and Roots I, 1999. Functional significance of a C–>A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. British Journal of Clinical Pharmacology, 47, 445–449.
248. Sale C, Harris RC, Delves S and Corbett J, 2006. Metabolic and physiological effects of ingesting extracts of bitter orange, green tea and guarana at rest and during treadmill walking in overweight males. International Journal of Obesity (London), 30, 764–773.
249. SCF (Scientific Committee for Food), 1983. Report of the Scientific Committee for Food on caffeine. EUR 8752, 10 pp.
250. SCF (Scientific Committee on Food), 1999. Opinion on Caffeine, Taurine and D-Glucurono -γ-Lactone as constituents of so-called “energy” drinks. 15 pp.
251. SCF (Scientific Committee on Food), 2000. Guidelines of the Scientific Committee on Food for the development of tolerable upper intake levels for vitamins and minerals. 6 pp.
252. SCF (Scientific Committee on Food), 2003. Opinion of the Scientific Committee on Food on Additional information on “energy” drinks. SCF/CS/PLEN/ENDRINKS/16 Final, 26 pp.
253. Seifert JG, Nelson A, Devonish J, Burke ER and Stohs SJ, 2011. Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans. International Journal of Medical Sciences, 8, 192–197.
254. Selb Semerl J and Selb K, 2004. Coffee and alcohol consumption as triggering factors for sudden cardiac death: case-crossover study. Croatian Medical Journal, 45, 775–780.
255. Sengpiel V, Elind E, Bacelis J, Nilsson S, Grove J, Myhre R, Haugen M, Meltzer HM, Alexander J, Jacobsson B and Brantsaeter AL, 2013. Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study. BMC Medicine, 11, 42.
256. SHC (Superior Health Council), 2012. “The use of caffeine in foodstuffs”. No 8689, 27 pp. http://health.belgium.be/internet2Prd/groups/public/@public/@shc/documents/ie2divers/19076526_en.pdf.
257. Shen J, Johnson VM, Sullivan LM, Jacques PF, Magnani JW, Lubitz SA, Pandey S, Levy D, Vasan RS, Quatromoni PA, Junyent M, Ordovas JM and Benjamin EJ, 2011. Dietary factors and incident atrial fibrillation: the Framingham Heart Study. American Journal of Clinical Nutrition, 93, 261–266.
258. Shi J, Benowitz NL, Denaro CP and Sheiner LB, 1993. Pharmacokinetic-pharmacodynamic modeling of caffeine: tolerance to pressor effects. Clinical Pharmacology and Therapeutics, 53, 6–14.
259. Signorello LB, Nordmark A, Granath F, Blot WJ, McLaughlin JK, Anneren G, Lundgren S, Ekbom A, Rane A and Cnattingius S, 2001. Caffeine metabolism and the risk of spontaneous abortion of normal karyotype fetuses. Obstetrics and Gynecology, 98, 1059–1066.
260. Silletta MG, Marfisi R, Levantesi G, Boccanelli A, Chieffo C, Franzosi M, Geraci E, Maggioni AP, Nicolosi G, Schweiger C, Tavazzi L, Tognoni G, Marchioli R and Gissipi, 2007. Coffee consumption and risk of cardiovascular events after acute myocardial infarction - Results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial. Circulation, 116, 2944–2951.
261. Silva AM, Judice PB, Matias CN, Santos DA, Magalhaes JP, St-Onge MP, Goncalves EM, Armadada-Silva P and Sardinha LB, 2013. Total body water and its compartments are not affected by ingesting a moderate dose of caffeine in healthy young adult males. Applied Physiology, Nutrition, and Metabolism, 38, 626–632.
262. SLE (Swedish National Food Agency), 2010. List of plants and plant parts unsuitable for use in food (VOLM). http://www.slv.se/upload/nfa/documents/food_safety/lists_plants_2010.pdf.
263. Sofi F, Conti AA, Gori AM, Eliana Luisi ML, Casini A, Abbate R and Gensini GF, 2007. Coffee consumption and risk of coronary heart disease: a meta-analysis. Nutrition, Metabolism and Cardiovascular Disease, 17, 209–223.
264. Souza D, Casonatto J, Poton R, Willardson J and Polito M, 2014. Acute effect of caffeine intake on hemodynamics after resistance exercise in young non-hypertensive subjects. Research in Sports Medicine, 22, 253–264.
265. Steer P, Flenady V, Shearman A, Charles B, Gray PH, Henderson-Smart D, Bury G, Fraser S, Hegarty J, Rogers Y, Reid S, Horton L, Charlton M, Jacklin R, Walsh A and Caffeine Collaborative Study Group Steering G, 2004. High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Archives of Disease in Childhood. Fetal and Neonatal Edition, 89, F499–503.
266. Steer PA, Flenady VJ, Shearman A, Lee TC, Tudehope DI and Charles BG, 2003. Periextubation caffeine in preterm neonates: a randomized dose response trial. Journal of Paediatrics and Child Health, 39, 511–515.
267. Steffen M, Kuhle C, Hensrud D, Erwin PJ and Murad MH, 2012. The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis. Journal of Hypertension, 30, 2245–2254.
268. Stein MA, Krasowski M, Leventhal BL, Phillips W and Bender BG, 1996. Behavioral and cognitive effects of methylxanthines. A meta-analysis of theophylline and caffeine. Archives of Pediatrics & Adolescent Medicine, 150, 284–288.
269. Stensvold I and Tverdal A, 1995. The relationship of coffee consumption to various self-reported cardiovascular events in middle-aged Norwegian men and women. Scandinavian Journal of Social Medicine, 23, 103–109.
270. Stohs SJ, Preuss HG, Keith SC, Keith PL, Miller H and Kaats GR, 2011. Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes. International Journal of Medical Sciences, 8, 295–301.
271. Stohs SJ, Preuss HG and Shara M, 2012. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine. International Journal of Medical Sciences, 9, 527–538.
272. Strandhagen E and Thelle DS, 2003. Filtered coffee raises serum cholesterol: results from a controlled study. European Journal of Clinical Nutrition, 57, 1164–1168.
273. Stuart GR, Hopkins WG, Cook C and Cairns SP, 2005. Multiple effects of caffeine on simulated high-intensity team-sport performance. Medicine & Science in Sports & Exercise, 37, 1998–2005.
274. Sugiyama K, Kuriyama S, Akhter M, Kakizaki M, Nakaya N, Ohmori-Matsuda K, Shimazu T, Nagai M, Sugawara Y, Hozawa A, Fukao A and Tsuji I, 2010. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. Journal of Nutrition, 140, 1007–1013.
275. Sulem P, Gudbjartsson DF, Geller F, Prokopenko I, Feenstra B, Aben KK, Franke B, den Heijer M, Kovacs P, Stumvoll M, Magi R, Yanek LR, Becker LC, Boyd HA, Stacey SN, Walters GB, Jonasdottir A, Thorleifsson G, Holm H, Gudjonsson SA, Rafnar T, Bjornsdottir G, Becker DM, Melbye M, Kong A, Tonjes A, Thorgeirsson T, Thorsteinsdottir U, Kiemeney LA and Stefansson K, 2011. Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. Human Molecular Genetics, 20, 2071–2077.
276. Sundhedsstyrelsen, 2008. The Danish Medicines Agency and the Danish Veterinary and Food Administration warn against the weight loss product “Therma Power”. 30 January 2008. http://sundhedsstyrelsen.dk/en/medicines/find-medicines/lists-with-information-about-medicinal-products/Advarsler%20mod%20produkter/the-danish-medicines-agency-and-the-danish-veterinary-and-food-administration-warn-against-the-weight-loss-product-therma-power.
277. Superko HR, Bortz W, Jr., Williams PT, Albers JJ and Wood PD, 1991. Caffeinated and decaffeinated coffee effects on plasma lipoprotein cholesterol, apolipoproteins, and lipase activity: a controlled, randomized trial. American Journal of Clinical Nutrition, 54, 599–605.
278. Superko HR, Myll J, DiRicco C, Williams PT, Bortz WM and Wood PD, 1994. Effects of cessation of caffeinated-coffee consumption on ambulatory and resting blood pressure in men. American Journal of Cardiology, 73, 780–784.
279. Swampillai J, Rakebrandt F, Morris K, Jones CJ and Fraser AG, 2006. Acute effects of caffeine and tobacco on arterial function and wave travel. European Journal of Clinical Investigation, 36, 844–849.
280. Tantcheva-Poor I, Zaigler M, Rietbrock S and Fuhr U, 1999. Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics, 9, 131–144.
281. Tejani FH, Thompson RC, Kristy R and Bukofzer S, 2014. Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study. International Journal of Cardiovascular Imaging, 30, 979–989.
282. Tracy TS, Venkataramanan R, Glover DD, Caritis SN, National Institute for Child H and Human Development Network of Maternal-Fetal-Medicine U, 2005. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. American Journal of Obstetrics and Gynecology, 192, 633–639.
283. Tsutsumi K, Kotegawa T, Matsuki S, Tanaka Y, Ishii Y, Kodama Y, Kuranari M, Miyakawa I and Nakano S, 2001. The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans. Clinical Pharmacology and Therapeutics, 70, 121–125.
284. Tverdal A, Stensvold I, Solvoll K, Foss OP, Lund-Larsen P and Bjartveit K, 1990. Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women. British Medical Journal, 300, 566–569.
285. Uiterwaal CS, Verschuren WM, Bueno-de-Mesquita HB, Ocke M, Geleijnse JM, Boshuizen HC, Peeters PH, Feskens EJ and Grobbee DE, 2007. Coffee intake and incidence of hypertension. American Journal of Clinical Nutrition, 85, 718–723.
286. Umemura T, Ueda K, Nishioka K, Hidaka T, Takemoto H, Nakamura S, Jitsuiki D, Soga J, Goto C, Chayama K, Yoshizumi M and Higashi Y, 2006. Effects of acute administration of caffeine on vascular function. American Journal of Cardiology, 98, 1538–1541.
287. Van Dusseldorp M, Smits P, Thien T and Katan MB, 1989. Effect of decaffeinated versus regular coffee on blood pressure. A 12-week, double-blind trial. Hypertension, 14, 563–569.
288. Van Dusseldorp M, Smits P, Lenders JW, Thien T and Katan MB, 1991. Boiled coffee and blood pressure. A 14-week controlled trial. Hypertension, 18, 607–613.
289. Verster JC, Aufricht C and Alford C, 2012. Energy drinks mixed with alcohol: misconceptions, myths, and facts. International Journal of General Medicine, 5, 187–198.
290. Vlachopoulos C, Hirata K and O'Rourke MF, 2003. Effect of caffeine on aortic elastic properties and wave reflection. Journal of Hypertension, 21, 563–570.
291. Vlachopoulos C, Alexopoulos N, Dima I, Aznaouridis K, Andreadou I and Stefanadis C, 2006. Acute effect of black and green tea on aortic stiffness and wave reflections. Journal of the American College of Nutrition, 25, 216–223.
292. Waizenegger J, Castriglia S, Winkler G, Schneider R, Ruge W, Kersting M, Alexy U and Lachenmeier DW, 2011. Caffeine exposure in children and adolescents consuming ready-to-drink coffee products. Journal of Caffeine Research, 1, 200–205.
293. Wang H, Zhang Z, Han S, Lu Y, Feng F and Yuan J, 2012. CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case–control studies. BMC Cancer, 12, 528.
294. Wang Y, Tuomilehto J, Jousilahti P, Antikainen R, Mahonen M, Mannisto S, Katzmarzyk PT and Hu G, 2011. Coffee consumption and the risk of heart failure in Finnish men and women. Heart (British Cardiac Society), 97, 44–48.
295. Watson JM, Jenkins EJ, Hamilton P, Lunt MJ and Kerr D, 2000. Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care, 23, 455–459.
296. Weathersbee PS and Lodge JR, 1977. Caffeine: its direct and indirect influence on reproduction. Journal of Reproductive Medicine, 19, 55–63.
297. Wilhelmsen L, Tibblin G, Elmfeldt D, Wedel H and Werko L, 1977. Coffee consumption and coronary heart disease in middle-aged Swedish men. Acta Medica Scandinavica, 201, 547–552.
298. Wilhelmsen L, Rosengren A and Lappas G, 2001a. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. Journal of Internal Medicine, 250, 382–389.
299. Wilhelmsen L, Rosengren A, Eriksson H and Lappas G, 2001b. Heart failure in the general population of men - morbidity, risk factors and prognosis. Journal of Internal Medicine, 249, 253–261.
300. Wilson PW, Garrison RJ, Kannel WB, McGee DL and Castelli WP, 1989. Is coffee consumption a contributor to cardiovascular disease? Insights from the Framingham Study. Archives of Internal Medicine, 149, 1169–1172.
301. Winkelmayer WC, Stampfer MJ, Willett WC and Curhan GC, 2005. Habitual caffeine intake and the risk of hypertension in women. Journal of the American Medical Association, 294, 2330–2335.
302. Woodward M and Tunstall-Pedoe H, 1999. Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. Journal of Epidemiology and Community Health, 53, 481–487.
303. Worthley MI, Prabhu A, De Sciscio P, Schultz C, Sanders P and Willoughby SR, 2010. Detrimental effects of energy drink consumption on platelet and endothelial function. American Journal of Medicine, 123, 184–187.
304. Wu JN, Ho SC, Zhou C, Ling WH, Chen WQ, Wang CL and Chen YM, 2009. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. International Journal of Cardiology, 137, 216–225.
305. Yang A, Palmer AA and De Wit H, 2010. Genetics of caffeine consumption and responses to caffeine. Psychopharmacology (Berlin), 211, 245–257.
306. Yano K, Reed DM and Cj. M, 1987. Coffee consumption and the incidence of coronary heart disease. New England Journal of Medicine, 316, 945–947.
307. Zahn TP and Rapoport JL, 1987. Acute autonomic nervous system effects of caffeine in prepubertal boys. Psychopharmacology (Berlin), 91, 40–44.
308. Zhang W, Lopez-Garcia E, Li TY, Hu FB and Van Dam RM, 2009. Coffee consumption and risk of cardiovascular diseases and all-cause mortality among men with type 2 diabetes. Diabetes Care, 32, 1043–1045.
309. Zhang WL, Lopez-Garcia E, Li TY, Hu FB and Van Dam RM, 2009a. Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia, 52, 810–817.
310. Zhang WL, Lopez-Garcia E, Li TY, Hu FB and Van Dam RM, 2009b. Coffee consumption and risk of cardiovascular disease and total mortality among women with type 2 diabetes. Circulation, 119, E298–E298.
311. Zhang Z, Hu G, Caballero B, Appel L and Chen L, 2011. Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies. American Journal of Clinical Nutrition, 93, 1212–1219.
312. Zucconi S, Volpato C, Adinolfi F, Gandini E, Gentile E, Loi A and Fioriti L, 2013. Gathering consumption data on specific consumer groups of energy drinks. Supporting Publications. 190 pp.